Glucagon-like Peptide (GLP) Utilization and Safety

Clinical trial NCT01767389 · COMPLETED

Trial details

NCT number: NCT01767389
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Diabetes Mellitus, Type 2

Start date: 2012-09-01
Primary completion: 2013-12-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.